Introduction Limited data exist on flavoured non-cigarette tobacco product (NCTP) use among US adults.
Methods Data from the 2013 to 2014 National Adult Tobacco Survey (N=75 233), a landline and cellular telephone survey of US adults aged ≥18, were assessed to estimate past 30-day NCTP use, flavoured NCTP use and flavour types using bivariate analyses.
Results During 2013–2014, 14.4% of US adults were past 30-day NCTP users. Nationally, an estimated 10.2 million e-cigarette users (68.2%), 6.1 million hookah users (82.3%), 4.1 million cigar smokers (36.2%) and 4.0 million smokeless tobacco users (50.6%) used flavoured products in the past 30 days. The most prevalent flavours reported were menthol/mint (76.9%) for smokeless tobacco; fruit (74.0%) for hookah; fruit (52.4%), candy/chocolate/other sweet flavours (22.0%) and alcohol (14.5%) for cigars/cigarillos/filtered little cigars; fruit (44.9%), menthol/mint (43.9%) and candy/chocolate/other sweet flavours (25.7%) for e-cigarettes and fruit (56.6%), candy/chocolate/other sweet flavours (26.5%) and menthol/mint (24.8%) for pipes. Except for hookah and pipes, past 30-day flavoured product use was highest among 18–24-year olds. By cigarette smoking, never smoking e-cigarette users (84.8%) were more likely to report flavoured e-cigarette use, followed by recent former smokers (78.1%), long-term former smokers (70.4%) and current smokers (63.2%).
Conclusions Flavoured NCTP use is prominent among US adult tobacco users, particularly among e-cigarette, hookah and cigar users. Flavoured product use, especially fruit and sweet-flavoured products, was higher among younger adults. It is important for tobacco prevention and control strategies to address all forms of tobacco use, including flavoured tobacco products.
- Non-cigarette tobacco products
- Surveillance and monitoring
- Priority/special populations
- Electronic nicotine delivery devices
Statistics from Altmetric.com
Contributors BKA and MGB developed the concept and design of the study. EH-H analysed the data, in consultation with MGB; MGB, EH-H, BKA and BJA interpreted the data; MGB prepared the initial manuscript; EH-H, BKA, BJA, SPF, CT and BAK critically reviewed and revised the manuscript for important intellectual content. All authors read and approved the final manuscript as submitted.
Funding This work was supported by the Food and Drug Administration's Center for Tobacco Products and the Centers for Disease Control and Prevention's Office of Smoking and Health.
Disclaimer The findings and conclusions in this report are those of the authors. The information in this article is not a formal dissemination of information by either FDA or CDC and does not represent either agency's positions or policies.
Competing interests None declared.
Ethics approval ICF International's Institutional Review Board.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.